Melatonin–Microbiome Two-Sided Interaction in Dysbiosis-Associated Conditions
Mara Ioana Iesanu,Carmen Denise Mihaela Zahiu,Ioana-Alexandra Dogaru,Diana Maria Chitimus,Gratiela Gradisteanu Pircalabioru,Suzana Elena Voiculescu,Sebastian Isac,Felicia Galos,Bogdan Pavel,Ana-Maria Zagrean,Siobhain M. O'Mahony
DOI: https://doi.org/10.3390/antiox11112244
IF: 7.675
2022-11-15
Antioxidants
Abstract:Melatonin is a pineal indolamine, allegedly known as a circadian rhythm regulator, and an antioxidative and immunomodulatory molecule. In both experimental and clinical trials, melatonin has been shown to have positive effects in various pathologies, as a modulator of important biochemical pathways including inflammation, oxidative stress, cell injury, apoptosis, and energy metabolism. The gut represents one of melatonin's most abundant extra pineal sources, with a 400-times-higher concentration than the pineal gland. The importance of the gut microbial community—namely, the gut microbiota, in multiple critical functions of the organism— has been extensively studied throughout time, and its imbalance has been associated with a variety of human pathologies. Recent studies highlight a possible gut microbiota-modulating role of melatonin, with possible implications for the treatment of these pathologies. Consequently, melatonin might prove to be a valuable and versatile therapeutic agent, as it is well known to elicit positive functions on the microbiota in many dysbiosis-associated conditions, such as inflammatory bowel disease, chronodisruption-induced dysbiosis, obesity, and neuropsychiatric disorders. This review intends to lay the basis for a deeper comprehension of melatonin, gut microbiota, and host-health subtle interactions.
biochemistry & molecular biology,chemistry, medicinal,food science & technology